Supha Pharmachem Limited (BOM:539561)
India · Delayed Price · Currency is INR 0.3300
+0.0100 (3.13%)
At close: Jul 31, 2026
Supha Pharmachem Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 13.16 | 14.27 | 15.24 | 218.56 | 14.36 | 8.11 |
Cash & Short-Term Investments | 13.16 | 14.27 | 15.24 | 218.56 | 14.36 | 8.11 |
Cash Growth | -74.27% | -6.35% | -93.03% | 1422.30% | 77.07% | -12.37% |
Accounts Receivable | 6,678 | 7,716 | 9,206 | 1,724 | 639.96 | 236.84 |
Other Receivables | - | 23.26 | 4.37 | 21.83 | 113.94 | - |
Receivables | 13,529 | 7,739 | 9,210 | 1,746 | 753.9 | 236.84 |
Inventory | 2,608 | 2,694 | 1,332 | 73.21 | 838.73 | 31.08 |
Prepaid Expenses | - | - | - | - | 4.67 | 3.5 |
Other Current Assets | 22.93 | 6,756 | 8,921 | 9,504 | 624.05 | 103.7 |
Total Current Assets | 16,173 | 17,203 | 19,478 | 11,541 | 2,236 | 383.24 |
Property, Plant & Equipment | 58.32 | 0.08 | 0.47 | 0.78 | 0.85 | 0.73 |
Long-Term Deferred Tax Assets | 0.36 | 0.36 | 0.27 | 0.07 | - | - |
Long-Term Deferred Charges | - | - | - | - | 1.01 | 1.37 |
Other Long-Term Assets | - | - | - | - | - | 0 |
Total Assets | 16,232 | 17,203 | 19,479 | 11,542 | 2,238 | 385.34 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Accounts Payable | 3,964 | 5,010 | 7,123 | 842.18 | 1,246 | 237.72 |
Accrued Expenses | - | 0.8 | - | 0.31 | 0.93 | 1.58 |
Short-Term Debt | 10,875 | 11,414 | 577.03 | - | - | - |
Current Income Taxes Payable | - | 224.29 | 182.72 | 24.28 | 4.51 | 1.73 |
Other Current Liabilities | 340.01 | 115.93 | 11,167 | 10,572 | 937.12 | 0.68 |
Total Current Liabilities | 15,180 | 16,765 | 19,050 | 11,439 | 2,188 | 241.71 |
Long-Term Debt | - | - | - | - | - | 105.01 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 0 | 0.03 |
Other Long-Term Liabilities | 0 | -0 | - | - | - | - |
Total Liabilities | 15,180 | 16,765 | 19,050 | 11,439 | 2,188 | 346.76 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Common Stock | 881.99 | 403.2 | 100.8 | 36 | 36 | 36 |
Retained Earnings | 170 | 35.71 | 328.78 | 67.64 | 13.38 | 2.58 |
Shareholders' Equity | 1,052 | 438.91 | 429.58 | 103.64 | 49.38 | 38.58 |
Total Liabilities & Equity | 16,232 | 17,203 | 19,479 | 11,542 | 2,238 | 385.34 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Total Debt | 10,875 | 11,414 | 577.03 | - | - | 105.01 |
Net Cash (Debt) | -10,862 | -11,400 | -561.79 | 218.56 | 14.36 | -96.91 |
Net Cash Growth | - | - | - | 1422.30% | - | - |
Net Cash Per Share | -16.74 | -28.27 | -1.39 | 0.54 | 0.04 | -0.24 |
Filing Date Shares Outstanding | 884.81 | 403.2 | 403.2 | 403.2 | 403.2 | 403.2 |
Total Common Shares Outstanding | 884.81 | 403.2 | 403.2 | 403.2 | 403.2 | 403.2 |
Working Capital | 993.31 | 438.47 | 428.84 | 102.79 | 47.52 | 141.52 |
Book Value Per Share | 1.19 | 1.09 | 1.07 | 0.26 | 0.12 | 0.10 |
Tangible Book Value | 1,052 | 438.91 | 429.58 | 103.64 | 49.38 | 38.58 |
Tangible Book Value Per Share | 1.19 | 1.09 | 1.07 | 0.26 | 0.12 | 0.10 |
Machinery | - | 2.23 | 2.23 | 1.98 | 1.55 | 1.05 |